We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Deep Learning Model Predicts Alzheimer’s Disease Outcomes from Baseline MRI

By HospiMedica International staff writers
Posted on 22 May 2026

Alzheimer’s disease, which accounts for 60% to 70% of dementia cases worldwide, remains difficult to predict early in its course. More...

Accurate prognostication typically relies on neuropsychological testing, multiple biomarkers, and advanced imaging, which are time-consuming and not universally accessible. Access to comprehensive cognitive assessment is a particular bottleneck. To help address this challenge, researchers have now developed an AI approach that estimates diagnosis and future cognition from a single baseline MRI scan plus demographics.

Developed at the University of California, San Francisco (UCSF), the domain knowledge–informed, multitask deep learning framework is built to derive clinically relevant outcomes from routine brain MRI. The strategy couples custom models with large pretrained networks and integrates demographic variables to estimate cognitive scores without any baseline cognitive testing. A key design element is an image model trained on related tasks—segmentation of gray matter, white matter, and cerebrospinal fluid—to overcome limitations of off‑the‑shelf systems.

In a study published in Nature Aging on May 18, 2026, the framework outperformed existing artificial intelligence methods, including standard transfer learning. From a single baseline scan, it produced accurate, field‑leading prediction of Alzheimer’s diagnosis, high‑quality tissue segmentation, and both current and future cognitive scores. The approach minimizes reliance on specialized image pipelines, positron emission tomography, genetic testing, or fluid proteomics.

Training, testing, and validation used the Alzheimer’s Disease Neuroimaging Initiative, which provided MRI, diagnosis, demographics, and cognitive assessments. To expose the model to brains with minimal or no atrophy, the team incorporated scans from the Human Connectome Project Young Adult cohort during training. External evaluation on the Dallas Lifespan Brain Study indicated improved generalizability and robustness of the segmentation models and reduced susceptibility to segmentation errors in downstream tasks.

The authors noted potential to clarify relationships between brain morphology and cognition beyond Alzheimer’s disease, including Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease. Predicting baseline cognition from minimal input could support triage in community settings and streamline enrollment by distinguishing progressors from non‑progressors, potentially reducing trial sample sizes and cost. Future iterations may integrate longitudinal MRI and PET, genetics, and blood or cerebrospinal fluid biomarkers, with real‑world adoption dependent on careful, use‑case‑specific assessment.

"The ability to correctly predict progressors from non-progressors using only baseline data can dramatically reduce sample sizes and cost. Our model may also have potential as a tool for patient selection and progression tracking in large clinical trials of disease-modifying drugs," Ashish Raj, Ph.D., UCSF professor of Radiology and Biomedical Imaging.

Related Links
UCSF


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hypodermic Syringe
SurTract™ Safety Syringe
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Design-science framework integrating CML and LLM pipelines for supply chain risk evaluation. (Gupta I, Konduru H, Correa S, et al. A causal analytics approach for interpretable supply chain risk and supplier performance evaluation. Supply Chain Analytics, 2026. doi:10.1016/j.sca.2026.100248)

Causal AI Tool Withholds Ovarian Cancer Treatment Recommendations When Evidence Insufficient

Ovarian cancer treatment often requires individualized decisions, particularly when available patient data do not clearly favor one therapeutic approach. However, artificial intelligence (AI) systems may... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.